Tradestie Institutional Equity Comparison Engine

COCP vs AYTU โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AYTU Overall Edge

AYTU Captures Institutional Edge (2โ€“1 Pillars ยท 6โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to AYTU BioPharma, Inc. Common Stock (AYTU) driven by superior Valuation, Growth & Margin while COCP counters with relative strength in Momentum & Technical. Fundamentally, COCP trades at N/M Forward P/E with -3063.6% operating margin (+26.9% YoY revenue) versus AYTU at 9.2x Forward P/E and -14.4% operating margin (+6.4% YoY). In options structure, COCP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against AYTU sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner AYTU
COCP N/M vs AYTU 9.2x Fwd P/E
Growth & Margin Winner AYTU
Op Margin -3063.6% vs -14.4% ยท YoY +26.9% vs +6.4%
Momentum & Technical Winner COCP
1Y -3.0% vs -12.1% ยท 52W Pos 19% vs 5%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
COCP NASDAQ
Cocrystal Pharma, Inc. Common Stock
Pharmaceutical Preparations
$1.00
+1.98% 1D
Market Cap $19.6M
1M Return -2.01%
1Y Return -2.96%
Forward P/E N/M
Unified AI Score
47.1 / 100 HOLD
Tech 51.0 Fund 48.0 Flow 50.0 Mom 54.0
AYTU NASDAQ
AYTU BioPharma, Inc. Common Stock
Pharmaceutical Preparations
$1.81
+1.69% 1D
Market Cap $19.6M
1M Return -11.27%
1Y Return -12.14%
Forward P/E 9.2x
Unified AI Score
48.9 / 100 HOLD
Tech 49.0 Fund 53.0 Flow 50.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: COCP -2.96% AYTU -12.14% Spread: +9.18 pp (COCP Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period COCP Revenue AYTU Revenue COCP Op. Margin AYTU Op. Margin Margin Edge
FY2019 $10M $10M -737.4% -230.1% AYTU
FY2020 $0M $30M -476.0% -76.5% AYTU
FY2021 N/A $70M N/A -89.7% AYTU
FY2022 N/A $100M N/A -113.7% AYTU
FY2023 N/A $110M N/A -15.9% AYTU
FY2024 N/A $70M N/A -2.4% AYTU
FY2025 N/A $70M N/A -11.8% AYTU
FY2026 N/A $60M N/A -14.4% AYTU

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: COCP (3) vs AYTU (6)
Institutional Metric COCP AYTU Criterion Row Winner
Market Capitalization Scale $19.6M $19.6M Larger Scale Tie
Trailing P/E Ratio Valuation N/M 9.2x Lower Multiple AYTU
Forward P/E Ratio Valuation N/M 9.2x Lower Multiple AYTU
Revenue Growth (YoY) Growth +26.9% +6.4% Higher Growth COCP
Operating Margin (TTM) Profitability -3063.6% -14.4% Higher Margin AYTU
Net Profit Margin Profitability 0.0% -24.8% Higher Margin COCP
Return on Equity (ROE) Capital Efficiency -311.7% -52.5% Higher ROE AYTU
52-Week Range Position Momentum 19% ($1โ€“$2) 5% ($2โ€“$3) Stronger Trend COCP
Beta / 30D Volatility Risk Regime 1.04ฮฒ ยท 54% Vol 0.65ฮฒ ยท 35% Vol Lower Realized Risk AYTU
Unified Institutional Score Composite Signal 47.1 / 100 (HOLD) 48.9 / 100 (HOLD) Higher Composite AYTU

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full COCP vs AYTU Buy Guide
COCP UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live COCP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AYTU UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AYTU Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither COCP nor AYTU registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.